{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "HBM HOLDINGS-B", "longName": "HBM Holdings Limited", "messageBoardId": "finmb_693912695", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "market": "hk_market", "esgPopulated": false, "regularMarketChangePercent": -2.0202003, "regularMarketPrice": 1.94, "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.5688889, "fiftyTwoWeekLow": 0.87, "fiftyTwoWeekHigh": 4.5, "earningsTimestamp": 1680087540, "earningsTimestampStart": 1680087540, "earningsTimestampEnd": 1680087540, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.55, "epsForward": -0.6, "epsCurrentYear": -0.7, "priceEpsCurrentYear": -2.7714286, "sharesOutstanding": 744323008, "bookValue": 0.128, "fiftyDayAverage": 2.203, "fiftyDayAverageChange": -0.263, "fiftyDayAverageChangePercent": -0.119382665, "twoHundredDayAverage": 2.3342, "twoHundredDayAverageChange": -0.39419985, "twoHundredDayAverageChangePercent": -0.16888008, "marketCap": 1443986688, "forwardPE": -3.2333333, "priceToBook": 15.15625, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 3, "regularMarketChange": -0.03999996, "regularMarketTime": 1683878916, "regularMarketDayHigh": 2.0, "regularMarketDayRange": "1.93 - 2.0", "regularMarketDayLow": 1.93, "regularMarketVolume": 386000, "regularMarketPreviousClose": 1.98, "bid": 1.94, "ask": 1.99, "fullExchangeName": "HKSE", "financialCurrency": "USD", "regularMarketOpen": 1.99, "averageDailyVolume3Month": 1511678, "averageDailyVolume10Day": 601100, "fiftyTwoWeekLowChange": 1.07, "fiftyTwoWeekLowChangePercent": 1.2298851, "fiftyTwoWeekRange": "0.87 - 4.5", "fiftyTwoWeekHighChange": -2.56, "firstTradeDateMilliseconds": 1607563800000, "symbol": "2142.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Tower A, 12th Floor", "address2": "Fenglin International Plaza Phase II 420 Fenglin Road Xuhui District", "city": "Shanghai", "zip": "200032", "country": "China", "phone": "86 21 5339 9123", "website": "https://www.harbourbiomed.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaboration on antibody-drug conjugate projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was incorporated in 2016 and is based in Shanghai, the People's Republic of China.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jingsong  Wang M.D., Ph.D.", "age": 57, "title": "Founder, Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2021, "totalPay": {"raw": 13267000, "fmt": "13.27M", "longFmt": "13,267,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Weihao  Xu", "age": 39, "title": "CFO, Chief Bus. Officer and Global Head of Bus. & Corp. Devel.", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yiping  Rong Ph.D.", "age": 45, "title": "Chief Scientific Officer & Exec. Director", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bruce  Zhang", "title": "Head of Legal", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter F. Moesta Ph.D.", "title": "Member of Scientific Advisory Board & Chief CMC Advisor", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Humphrey A. R. Gardner FCAP, M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Xiaolu  Tao", "age": 48, "title": "Chief Devel. Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wing Yat  Lui", "age": 32, "title": "Joint Company Sec.", "yearBorn": 1990, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yu  Fu", "age": 31, "title": "Joint Company Sec.", "yearBorn": 1991, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}